NCT07084103 Effectiveness of a Psychosocial Support Intervention for Women Diagnosed With Fetal Anomaly
| NCT ID | NCT07084103 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sakarya University |
| Condition | Fetal Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-04-01 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effectiveness of a psychosocial support intervention for women diagnosed with fetal anomaly. A randomized controlled trial design will be used, and women diagnosed with fetal anomaly will be included as participants. The intervention group will receive a structured psychosocial support program, while the control group will receive routine care.
Eligibility Criteria
Inclusion Criteria: * In her current pregnancy, the results of the dual or triple screening test (a screening test result of 1:50 or 1:100 is considered a high risk for Down syndrome (Şirin, 2020) and/or ultrasound findings (physical/anatomical and congenital anomalies) indicate a high risk of foetal abnormalities, * Decision to continue the pregnancy, * Being over 18 years of age, * Having received hospital services at least once after the initial diagnosis (this criterion was added to enable the pregnant woman to evaluate the services she received from the hospital after the diagnosis and to express her expectations beyond the services provided) * No mental or psychological disorders that would make it difficult to express oneself, * Voluntary participation in the study. Exclusion Criteria: • Pregnant women who do not meet the inclusion criteria will be excluded from the sample.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07084103 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Fetal Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07084103 currently recruiting?
Yes, NCT07084103 is actively recruiting participants. Contact the research team at semihaunkazan@sakarya.edu.tr for enrollment information.
Where is the NCT07084103 trial being conducted?
This trial is being conducted at Sakarya, Turkey (Türkiye).
Who is sponsoring the NCT07084103 clinical trial?
NCT07084103 is sponsored by Sakarya University. The trial plans to enroll 64 participants.